EMMA RODTS: Open Payments
NPI 1932970506 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $154 |
| ABBVIE INC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Corcept Therapeutics | 1 | $28 |
| Medtronic, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: Rybelsus, QULIPTA, CAPLYTA, Wegovy, Korlym, INCEPTIV, VRAYLAR, HETLIOZ.
Industry payments across NC — which companies pay providers there.
